Bringing the fundamentals into focus…
Back to Dianthus Therapeutics, Inc.
How Dianthus Therapeutics, Inc. stacks up
DNTH · against 223 other Healthcare companies of similar size
Growth
5/ 100
Near the bottom of its peers.
Ranked #217 of 224 · scores higher than 2% of peers
Bars: peers in each 10-point band of the growth score17 peers with a growth score of 0–9, including DNTH · Click a bar to see the companies
Why growth scores 5?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 97% of peers. Revenue growth: -67.3% vs peer median 6.1%
- slower revenue growth over three years: weaker than 96% of peers. 3-year revenue growth: -31.8% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = DNTH, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | DNTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 223 reported | -67.3% | 8.1% | 3% | 33% | |
| Earnings per share growthHigher is better · 142 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 216 reported | -31.8% | 8.9% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around DNTH| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 215 | 24.9B CNY (≈$3.5B) | 7 | 38 | |
| 216 | 3.7B USD | 6 | 28 | |
| 217 | 17.6B CNY (≈$2.5B) | 5 | 11 | |
| 217 | 4.8B USD | 5 | 27 | |
| 217 | 4.6B USD | 5 | 29 | |
| 220 | 31.0B CNY (≈$4.3B) | 4 | 26 | |
| 220 | 7.8B USD | 4 | 30 | |
| 222 | 2.3B USD | 3 | 26 | |
| 223 | 34.9B CNY (≈$4.9B) | 0 | 16 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score